Guidance - Page 3 of 5 - The British Society of Gastroenterology

Guidance

First published on 10 May 2018

UK consensus on non-medical staffing required to deliver safe, quality-assured care for adult patients undergoing gastrointestinal endoscopy

Authors Irene Dunkley, Helen Griffiths, Rachael Follows, Alison Ball, Mandy Collins, Phedra Dodds, Richard Gardner, Victoria Jackson, Claire Rodgers, Barbara Simpson, Nicky Taggart, Tony Tham, Vivienne Wilkin, Andrew Veitch Patients undergoing endoscopy procedures expect support and care from a competent […]

Guidance

First published on 06 Apr 2018

Cancer datasets and tissue pathways

The College’s Datasets for Histopathological Reporting on Cancers have been written to help pathologists work towards a consistent approach for the reporting of the more common cancers and to define the range of acceptable practice in handling pathology specimens.

Guidance

First published on 05 Apr 2018

Caution about the use of ulipristal acetate (Esmya)

Dear Liver Section members, I am writing to inform you of a significant caution about the use of ulipristal acetate (Esmya). Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women […]

Guidance

First published on 21 Feb 2018

NICE Guidance: Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C

Evidence-based recommendations on sofosbuvir–velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C in adults.

Guidance

First published on 21 Nov 2017

Endoscopy Global Rating Scale

Accreditation assessments for services in England, Wales, Northern Ireland and Scotland, including the independent sector are now conducted via https://www.thejag.org.uk

Guidance

First published on 04 Apr 2017

BSG guidance on the use of intravenous hyoscine butylbromide (buscopan) during gastrointestinal endoscopy

The MHRA has recently circulated a Drug Safety Update regarding the risk of serious adverse events following the use of intravenous Hyoscine Butylbromide (Buscopan) in patients with underlying cardiac disease. Buscopan is commonly used during endoscopic procedures. It induces smooth […]

Guidance

First published on 01 Feb 2017

NICE guidance on molecular testing strategies for Lynch syndrome in people with colorectal cancer

An estimated 175,000 people have Lynch syndrome in the UK, however 95% of those do not know they have it. NICE recommends that microsatellite instability (MSI) testing or immunohistochemistry (IHC) should be used on all colorectal cancers, when first diagnosed, […]

Guidance

First published on 04 Oct 2016

Rapid Colorectal Diagnostic Pathway

Following extensive discussion and a multi-stakeholder workshop with NHS England in late 2016 a set of principles has been agreed for a Rapid Colorectal Diagnostic Pathway following the introduction of a non-mandated Best Practice Tariff in England. The BSG recommends […]

Guidance

First published on 01 Oct 2016

Test and treat for Helicobacter pylori (HP) in Dyspepsia

Helicobacter pylori in dyspepsia: test and treat – consultation and guidance documents from Public Health England. Guidance for primary care/ CCGs published October 2016. This guidance has been endorsed by members of the BSG Gastroduodenal Section. https://www.gov.uk/government/publications/helicobacter-pylori-diagnosis-and-treatment

Guidance

First published on 01 Feb 2016

Treatment Recommendations for the management of patients with chronic HCV Infection

These recommendations were developed at a consensus meeting of clinicians and interested parties on 5 January 2016. Therapies that are NICE approved are presented in bold and those that are NICE unapproved are italicised. The prices of the different regimens […]